Skip to main content
. Author manuscript; available in PMC: 2019 Nov 18.
Published in final edited form as: Cancer Chemother Pharmacol. 2018 Dec 12;83(2):387–391. doi: 10.1007/s00280-018-3757-7

Figure 1.

Figure 1.

Figure 1.

Pharmacokinetics. (A) Pharmacokinetic parameters of gemcitabine and dFdU metabolite in plasma, and dFdCTP active metabolite in peripheral blood mononuclear cells (PBMC). Data are presented as Mean±SD. (B) Plasma concentration-time plots for subject 1.